John Messina
Optinose US Inc.
3
0
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Jennifer Carothers
Optinose US Inc.
Shared therapeutic areas:
Worked with same sponsors:
Adel El-Antably, Doctorate
Cairo University
Shared therapeutic areas:
Jochen G. Mainz, M.D.
University of Jena
Shared therapeutic areas:
Xie chenglan, PhD
The Affiliated Huaian Hospital of Xuzhou Medical University, Huai'an Second Hospital
Shared therapeutic areas:
Peter H Hwang, MD
Stanford University
Shared therapeutic areas:
Michael T Chang, MD
Stanford University
Shared therapeutic areas:
John Fahy, MD, MSc
University of California, San Francisco
Shared therapeutic areas:
Reham S. Fatehallah, Master
Cairo University
Shared therapeutic areas:
Daniyal Babar
Services Institute of Medical Sciences, Pakistan
Shared therapeutic areas:
Hussein Gamal Hussein Mogahed, PhD
Assistant Professor, Cairo university
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis Without the Presence of Nasal Polyps
Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis With or Without the Presence of Nasal Polyps
Efficacy & Safety of OPN-375 Adults With Bilateral Nasal Polyps Using Nasoendoscopic Video
All 3 trials loaded